ARCHIVED — Vol. 146, No. 10 — March 10, 2012
Regulations Amending Schedule D to the Food and Drugs Act (Blood)
Food and Drugs Act
Department of Health
REGULATORY IMPACT ANALYSIS STATEMENT
For the Regulatory Impact Analysis Statement, see Blood Regulations.
PROPOSED REGULATORY TEXT
Notice is hereby given that the Governor in Council, pursuant to section 30 (see footnote a) of the Food and Drugs Act (see footnote b), proposes to make the annexed Regulations Amending Schedule D to the Food and Drugs Act (Blood).
Interested persons may make representations concerning the proposed Regulations within 75 days after the date of publication of this notice. All such representations must cite the Canada Gazette, Part Ⅰ, and the date of publication of this notice and be addressed to Liz Anne Gillham-Eisen, Unit Manager, Office of Policy and International Collaboration, Director General’s Office, Biologics and Genetic Therapies Directorate, Health Products and Food Branch, Department of Health, Address Locator: 0702B, Health Protection Building, 200 Tunney’s Pasture Driveway, Ottawa, Ontario K1A 0K9 (fax: 613-952-5364; email: bgtd. email@example.com).
Ottawa, March 1, 2012
Assistant Clerk of the Privy Council
REGULATIONS AMENDING SCHEDULE D TO THE FOOD AND DRUGS ACT (BLOOD)
1. Schedule D to the Food and Drugs Act (see footnote 1) is amended by repealing the following:
Blood and blood derivatives, except cord blood and peripheral blood that are a source of lymphohematopoietic cells for transplantation
Sang et dérivés du sang...
2. Schedule D to the Act is amended by repealing the following:
Human plasma collected by plasmapheresis
3. Schedule D to the Act is amended by adding the following in alphabetical order:
Drugs that are or are made from blood
Drogue qui est...
COMING INTO FORCE
4. These Regulations come into force one year after the day on which they are published in the Canada Gazette , Part Ⅱ.
S.C. 2005, c. 42, s. 2
R.S., c. F-27
R.S., c. F-27